Apr 4 2018
Opiod lawsuits stymie an Endo turnaround, Mizuho says in downgrade
Mizuho | FirstWord Pharma
Apr 4 2018
Opioid Lawsuits Stymie An Endo Turnaround, Mizuho Says In Downgrade — MarketWatch
Mizuho | Dow Jones Newswires
Apr 3 2018
Why it Makes Sense for Allergan to Drop its Women’s Health Unit
Mizuho | FirstWord Pharma
Apr 3 2018
Celgene COO Scott Smith Exits Suddenly in Wake of MS Fumble, Otezla Shortfall
Mizuho | FiercePharma